Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • imsharmanitin
    Postdoc Cancer Bioinformatics
    • Dec 2014
    • 17

    #1

    is this a technical replicate or biological replicate

    i know that biological replicate is one taken from different organism/sample while technical replicate is one from same organism/sample.

    However, I am not able to understand that a cell line treated with a drug three times separately to generate RNA-Seq data will be considered as biological replicate or technical replicate or a biological replicate but not in a strict sense. Also, will this be applicable for control sample?

    Thanks in advance
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I think it would be biological replicates and the same goes for control which should be treated with solvent without the drug. I imagine that there will be other treatments such as exposure time and dose as well in such experiments.

    Comment

    • jaspersaris
      Member
      • Nov 2008
      • 6

      #3
      As the variation during cultering is expected (and often is) far more variable then the technical reproducibility the biological replicate would be to repeat the actual incubations i.e. three times (for a triplicate).
      A technical replicate would be having the same RNA sample sequenced two times (i.e. a duplo).
      Often an experiment is repeated three times, getting n=3 for the experiment and statistics. In the experiment an incubation can be in duplo (i.e. two flasks stimulated with the same compound). Each incubation is then sequenced once.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      51 views
      0 reactions
      Last Post SEQadmin2  
      Working...